Opus Genetics
IRD
14 hedge funds and large institutions have $14.5M invested in Opus Genetics in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
1,794% more capital invested
Capital invested by funds: $764K → $14.5M (+$13.7M)
18.3% more ownership
Funds ownership: 2.08% → 20.38% (+18%)
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Comerica Bank
Dallas,
Texas
|
+$207K |
| 2 |
Squarepoint
New York
|
+$135K |
| 3 |
Renaissance Technologies
New York
|
+$107K |
| 4 |
Morgan Stanley
New York
|
+$4.6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$55K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
-$48K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$32.1K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$48 |
| 5 |
BlackRock
New York
|
-$7 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
Altium Capital Management
New York
| $13.4M | +$14.3M | +2,068,530 | New |
|
|
2
Renaissance Technologies
New York
| $479K | +$107K | +15,494 | +27% |
|
|
3
Comerica Bank
Dallas,
Texas
| $322K | +$207K | +30,000 | New |
|
|
4
Squarepoint
New York
| $127K | +$135K | +19,572 | New |
|
|
5
Vanguard Group
Malvern,
Pennsylvania
| $93K | -$32.1K | -4,641 | -24% |
|
|
6
BlackRock
New York
| $15K | -$7 | -1 | -0% |
|
|
7
Morgan Stanley
New York
| $5K | +$4.6K | +666 | +1,959% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $3K | +$2.7K | +391 | +698% |
|
|
APA
9
American Portfolios Advisors
Holbrook,
New York
| $13 | – | – | – |
|
|
10
Geode Capital Management
Boston,
Massachusetts
| – | -$55K | -6,645 | Closed |
|
|
WS
11
Wedbush Securities
Los Angeles,
California
| – | -$48K | -5,825 | Closed |
|
|
12
Wells Fargo
San Francisco,
California
| – | -$48 | -7 | -64% |
|
|
NFG
13
Next Financial Group
Houston,
Texas
| – | -$7 | -1 | -2% |
|
14
Osaic Holdings
Scottsdale,
Arizona
| – | -$7 | -1 | -6% |
|
IRD Hedge Fund Activity: Q4 2020 in Review
14 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q4 2020, worth a combined $14.5M — up 1,794% from $764K a quarter earlier.
Fund positioning in IRD was balanced in Q4 2020: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 5 trimmed.
The largest buyer was Comerica Bank, opening a new position worth an estimated $207K. The largest seller was Geode Capital Management, exiting entirely with an estimated $55K sold.
- 14 institutional investors held Opus Genetics (IRD) as of Q4 2020, unchanged from Q3 2020.
- Funds reported $14.5M of Opus Genetics stock for Q4 2020, up 1,794% quarter-over-quarter.
- 3 funds opened new Opus Genetics positions in Q4 2020 and 3 closed out, a net change of 0 holders.
- The largest Opus Genetics buyer in Q4 2020 was Comerica Bank, an estimated $207K added.
- The largest Opus Genetics seller in Q4 2020 was Geode Capital Management, an estimated $55K sold.
Based on aggregated 13F filings for Q4 2020.